Dr. Lal Pathlabs
BSE: 539524 | NSE: LALPATHLAB | ISIN: INE600L01024 | SECTOR: Healthcare FacilitiesOpen
2,028.05High
2,057.10Low
2,015.20Prev Close
2,034.05P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
168.45BVolume
12.51KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
2,032.40Ask
-
Company Description
- Healthcare Facilities
BSE
539524NSE
LALPATHLABISIN
INE600L01024
Dr. Lal PathLabs Limited is engaged in providing diagnostic and related healthcare tests and services. The Company is also engaged in running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, and other pathological and radiological investigations. The Company offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, Dr. Lal PathLabs Nepal Private Limited, Dr. Lal PathLabs Bangladesh Pvt. Ltd. and Dr. Lal Ventures Private Limited.
Company Officers
Arvind Lal
Executive Chairman of the BoardBharath Uppiliappan
Chief Executive OfficerVed Goel
Chief Financial OfficerVinay Gujral
Compliance Officer, Company SecretaryOm Manchanda
Managing Director, Executive DirectorVandana Lal
Executive Director